BioCardia Announces Completion of Enrollment in Phase III Ca

SUNNYVALE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for ...

Related Keywords

California , United States , Maryland , Minnesota , Japan , Peter Altman , David Mcclung , Miranda Peto , Exchange Commission On , Medicaid Services , Maryland Stem Cell Research Fund , Biocardia Inc , Centers For Medicare , Cardiamp Cell Therapy Program , Failure Trial , Data Safety Monitoring Board , Minnesota Living , Heart Failure Questionnaire , Six Minute Walk Distance , Upcoming Milestones , Heart Failure Phase , Chronic Myocardial Ischemia Phase , Roll In Cohort , Randomized Pivotal , Cell Therapy , Heart Failure Trial , Looking Statements , Exchange Commission , Quarterly Reports , Chief Financial ,